• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Hamilton Lane Bolsters its Direct Equity Investment Team with Strategic Hires Across North America and Europe

    11/12/24 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email

     

    • The firm broadens its co-investment capabilities with the additions of five senior team members
    • Global appointments highlight continued growth within the asset class and historic success of the firm's Direct Equity platform, which stands at $15.3 billion in AUM*

     

    CONSHOHOCKEN, Pa., Nov. 12, 2024 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the expansion of its Direct Equity Investment Team, with the appointment of five new senior team members based in North America and Europe to support the continued growth of the asset class.

    Ken Binick, Co-Head of Direct Equity Investments

    Nelda Chang, Kyle McGinnis and Jenny Zhang recently joined the firm, based at Hamilton Lane's headquarters in Conshohocken. Chang plays a pivotal role in leading the origination, evaluation and due diligence of direct investment opportunities across North America. Prior to joining Hamilton Lane, Chang was a Principal at GCM Grosvenor, responsible for evaluating and executing private equity co-investments. She previously held roles at Headlands Capital and American Securities and began her career in the leveraged finance group at JPMorgan. McGinnis joined from Onex Partners, where he served as a Principal, responsible for the evaluation and execution of private equity investments. Previously, he worked at H.I.G. Capital on the middle market fund team and began his career as an investment banker with Wells Fargo Securities. Zhang joined from Two Sigma, where she was a Vice President on the private equity team and prior to that was on Carlyle's private equity team.

    Based in London, Aljoscha Dudek is responsible for the origination, evaluation and due diligence of direct equity opportunities across EMEA. Prior to joining the firm, Dudek was a Director at PSP Investments, responsible for the strategic development and management of a private equity portfolio in Europe. Chang, McGinnis, Zhang and Dudek all report to Ken Binick, Co-Head of Direct Equity Investments.

    Lastly, Benjamin Kalter has joined the firm's Impact Investment Team, where he is focused on the origination, evaluation and management of direct equity impact transactions. Kalter joined from Nuveen, where he served as a Vice President on the private equity impact investing team, executing growth equity investments across developed and developing markets. He is based in Conshohocken and reports to Dave Helgerson, Head of Impact Investments.

    Binick commented, "For firms like Hamilton Lane with strong investment capabilities and a large primary platform, we believe the co-investment landscape – particularly within the middle market – is ripe with opportunity. Our deal flow is at record levels, and we are happy to welcome Nelda, Aljoscha, Kyle, Jenny and Benjamin to our already talented, experienced team as we seek to execute on our strategy and strengthen our presence and expertise across the direct equity landscape globally."

    Drew Schardt, Vice Chairman, Head of Investment Strategy and Co-Head of Direct Equity, added, "These appointments further bolster our expertise and scale to support the historic success and AUM growth across our direct equity platform. Our direct equity investment strategy leverages the unique benefits of Hamilton Lane's platform and market access, enabling us to execute what we believe to be high-quality investments and construct portfolios that seek to deliver compelling returns for our investors."

    Hamilton Lane has been an active investor within the direct equity space for nearly 30 years, and today serves institutional and private wealth clients from around the world. The firm's Direct Equity Investment team comprises 45 individuals globally, growing nearly 40% over the past year across all levels. Hamilton Lane's Direct Equity platform represents approximately $15.3 billion in assets under management*.

    *AUM is as of September 30, 2024. Discretionary Assets Under Management ("AUM") includes all investments managed by Hamilton Lane for which Hamilton Lane retains a level of discretion for the investment decisions. AUM equals assets under management for active accounts. AUM is equal to market value plus unfunded. AUM calculation does not include authorized to invest amounts (ANI). ANI can only be attributed to commingled fund-of-funds and separate accounts and cannot be attributed to underlying investments.

    About Hamilton Lane

    Hamilton Lane (NASDAQ:HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 730 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has more than $947 billion in assets under management and supervision, composed of more than $131 billion in discretionary assets and approximately $816 billion in non-discretionary assets, as of September 30, 2024. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit our website or follow Hamilton Lane on LinkedIn.

    Forward-Looking Statements

    Some of the statements in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Words such as "will," "expect," "believe," "estimate," "continue," "anticipate," "intend," "plan" and similar expressions are intended to identify these forward-looking statements. Forward-looking statements discuss management's current expectations and projections relating to our financial position, results of operations, plans, objectives, future performance and business. All forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause actual results to be materially different, including risks relating to: our ability to manage growth, fund performance, competition in our industry, changes in our regulatory environment and tax status; market conditions generally; our ability to access suitable investment opportunities for our clients; our ability to maintain our fee structure; our ability to attract and retain key employees; our ability to manage our obligations under our debt agreements; defaults by clients and third-party investors on their obligations to fund commitments; our exposure and that of our clients and investors to the credit risks of financial institutions at which we and they hold accounts; our ability to comply with investment guidelines set by our clients; our ability to successfully integrate acquired businesses with ours; our ability to manage risks associated with introducing new types of investment structures, products or services or entering into strategic partnerships; our ability to manage redemption or repurchase rights in certain of our funds; our ability to manage, identify and anticipate risks we face; our ability to manage the effects of events outside of our control; and our ability to receive distributions from Hamilton Lane Advisors, L.L.C. to fund our payment of dividends, taxes and other expenses.

    The foregoing list of factors is not exhaustive. For more information regarding these risks and uncertainties as well as additional risks we face, you should refer to the "Risk Factors" detailed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and in our subsequent reports filed from time to time with the Securities and Exchange Commission. The forward-looking statements included in this release are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information or future events, except as otherwise required by law.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hamilton-lane-bolsters-its-direct-equity-investment-team-with-strategic-hires-across-north-america-and-europe-302302401.html

    SOURCE Hamilton Lane

    Get the next $HLNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    5/26/2023$87.00Perform → Outperform
    Oppenheimer
    3/15/2023$85.00Neutral → Overweight
    JP Morgan
    8/9/2022$72.00 → $75.00Buy → Neutral
    UBS
    More analyst ratings

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider French River 5 Ltd claimed ownership of 480,015 shares and claimed ownership of 7 units of Class B Common Stock (SEC Form 3)

      3 - Hamilton Lane INC (0001433642) (Issuer)

      4/25/25 5:05:37 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Delgado-Moreira Juan was granted 34,031 shares, increasing direct ownership by 3% to 1,298,847 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 5:00:47 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Hirsch Erik R. was granted 36,001 shares and covered exercise/tax liability with 3,386 shares, increasing direct ownership by 37% to 120,275 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 4:58:27 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    See more
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

      Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

      2/10/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation

      Experienced commercial leader joins Cosette to drive the next phase of growth and transformation Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette's generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203104224/en/Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire) "Cosette is

      2/3/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Launches U.S. Venture Capital and Growth Evergreen Fund, Further Expanding its $10B+ AUM Evergreen Platform

      Fund offers access to private venture and growth investments including disruptive technologies and innovative businesses CONSHOHOCKEN, Pa., May 6, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Venture Capital and Growth Fund ("HLVCG" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Act of 1940 ("40 Act"), available to accredited U.S. investor clients, including high-net-worth investors and their advisors2, as well as institutional investors. HLVCG offers investors in the U.S. access to the firm's global venture capital investment platform with what th

      5/6/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    SEC Filings

    See more

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      4/2/25 4:33:42 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      2/14/25 4:27:12 PM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Hamilton Lane INC (0001433642) (Filer)

      2/12/25 4:21:19 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/13/24 9:56:40 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/12/24 3:55:46 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/4/24 11:53:29 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Financials

    Live finance-specific insights

    See more
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families

      RED BANK, N.J., April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families. This strategic acquisition enhances PAX Health's portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company's ability to deliver high-quality psychiatric care across diverse

      4/17/25 8:27:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2025 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 11% AND ASSETS UNDER MANAGEMENT GROWING BY 12% YEAR-OVER-YEAR

      CONSHOHOCKEN, Pa., Feb. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2024. THIRD QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $134.7 billion grew $14.8 billion year-over-year. Fee-earning assets under management increased $7.9 billion to $71.0 billion over the same period.Revenue – Management and advisory fees of $126.3 million for the quarter represent growth of 11% versus the prior year period.Carried Interest – Unrealized carried interest balance of approximately $1.3 billion, up 15% versus the prior year

      2/4/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hamilton Lane upgraded by Oppenheimer with a new price target

      Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00

      1/21/25 7:49:57 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane downgraded by Goldman with a new price target

      Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00

      1/6/25 8:11:18 AM ET
      $HLNE
      Investment Managers
      Finance
    • Wells Fargo initiated coverage on Hamilton Lane with a new price target

      Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal Weight and set a new price target of $156.00

      9/12/24 7:41:15 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      11/13/24 4:31:06 PM ET
      $HLNE
      Investment Managers
      Finance